PCN69 - BUDGET IMPACT OF SUBSTITUTING BIOSIMILAR TRASTUZUMAB (CT-P6) IN TREATING GASTRIC CANCER AND BREAST CANCER IN 28 EUROPEAN COUNTRIES
Abstract
Authors
D. Suh S. Lee
D. Suh S. Lee
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now